[DOI] [PubMed] [Google Scholar] Hussain, M
There's a saying in marketing: "There's no such thing as bad publicity." It means that even if you are in the news negatively, there's often a positive effect on sales because your name is more well-known
However, the platform's impact on overall GLP-1 access might be limited, since prices there are likely still higher than those available through insurance or discount programs
A 12-week randomized controlled trial (RCT) on T2D patients recently described a reduction in food craving, preference for sweet foods, and improved dietary control with oral semaglutide compared with placebo, resulting in a decrease in body fat mass analyzed by plethysmography, without impairment of whole lean mass (48)
Semaglutide was associated with a significantly lower risk of opioid overdose during a 1-year follow-up compared with other antidiabetic medications, including other GLP-1RAs, with HRs ranging from 0.32 (95% CI, 0.12-0.89) to 0.58 (95% CI, 0.38-0.87) (Figure)
